{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:59:46Z","timestamp":1787950786404,"version":"build-2784847793"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the prevalence of extra-articular manifestations\u2014enthesitis, dactylitis, nail disease, uveitis and IBD\u2014in PsA, and their impact on longitudinal disease outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched Medline, PubMed, Scopus and Web of Science using a predefined protocol in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies using imaging to define extra-articular manifestations (EAMs) were excluded. Where possible, we performed meta-analyses of prevalence estimates, reported as percentages (95% CI). Heterogeneity (I2 statistic) was examined according to study characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 65 studies amounting to a total of 163\u2009299 PsA patients. Enthesitis was assessed in 29 studies with an average prevalence of 30% (95% CI: 24%, 38%). Dactylitis was reported in 35 studies with an average prevalence of 25% (95% CI: 20%, 31%). Nail disease was present in 60% (95% CI: 52%, 68%) across 26 studies, but definitions were often unclear. Uveitis (3.2%; 95% CI: 1.9%, 5.3%) and IBD (3.3%; 95% CI: 1.5%, 7.1%) were less common. Heterogeneity was high (&amp;gt;95%) in all meta-analyses, but could not be explained by study characteristics. No studies examined the impact of EAMs on longitudinal disease outcomes, except that dactylitis increases radiographic progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Enthesitis, dactylitis and nail disease are highly prevalent in PsA, but not uveitis and IBD. EAM patterns differ from axial SpA despite their shared disease mechanisms, which may help further understand differences between spondyloarthritides. More studies are needed on the impact of EAMs on disease outcomes such as response to treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa062","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:41:56Z","timestamp":1580229716000},"page":"2199-2206","source":"Crossref","is-referenced-by-count":74,"title":["Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"59","author":[{"given":"Bradley","family":"Pittam","sequence":"first","affiliation":[{"name":"School of Medicine, University of Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Gupta","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Academic Rheumatology, Liverpool University Hospitals"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Robertson","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Institute of Translational Medicine, University of Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3558-7353","authenticated-orcid":false,"given":"Sizheng Steven","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Academic Rheumatology, Liverpool University Hospitals"},{"name":"Musculoskeletal Biology, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"2020082623472017700_keaa062-B1","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2020082623472017700_keaa062-B2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","article-title":"European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update","volume":"75","author":"Gossec","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2020082623472017700_keaa062-B3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020082623472017700_keaa062-B4","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2020082623472017700_keaa062-B5","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"2020082623472017700_keaa062-B6","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s10067-016-3426-3","article-title":"Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art","volume":"35","author":"Fabiani","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2020082623472017700_keaa062-B7","first-page":"2667","article-title":"Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors","volume":"28","author":"Brophy","year":"2001","journal-title":"J Rheumatol"},{"key":"2020082623472017700_keaa062-B8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/rheumatology\/keh386","article-title":"A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis","volume":"43","author":"Robertson","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"2020082623472017700_keaa062-B9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.2003.018184","article-title":"Dactylitis in psoriatic arthritis: a marker for disease severity?","volume":"64","author":"Brockbank","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2020082623472017700_keaa062-B10","doi-asserted-by":"crossref","first-page":"e000802","DOI":"10.1136\/rmdopen-2018-000802","article-title":"Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis","volume":"5","author":"Winter","year":"2019","journal-title":"RMD Open"},{"key":"2020082623472017700_keaa062-B11","first-page":"411","article-title":"Psoriatic spondylitis: a clinical and radiological description of the spine in psoriatic arthritis","volume":"46","author":"Lambert","year":"1977","journal-title":"The Quarterly journal of medicine"},{"key":"2020082623472017700_keaa062-B12"},{"key":"2020082623472017700_keaa062-B13","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3899\/jrheum.150165","article-title":"The Swedish Early Psoriatic Arthritis Registry 5-year followup: substantial radiographic progression mainly in men with high disease activity and development of dactylitis","volume":"42","author":"Geijer","year":"2015","journal-title":"J Rheumatol"},{"key":"2020082623472017700_keaa062-B14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/rheumatology\/key371","article-title":"Associations between smoking and extra-axial manifestations and disease severity in axial spondyloarthritis: results from the BSR Biologics Register for Ankylosing Spondylitis (BSRBR-AS)","volume":"58","author":"Zhao","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2020082623472017700_keaa062-B15","first-page":"792","article-title":"Characterization of uveitis associated with spondyloarthritis","volume":"16","author":"Rosenbaum","year":"1989","journal-title":"J Rheumatol"},{"key":"2020082623472017700_keaa062-B16","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.180792","article-title":"Association between enthesitis and health-related quality of life in psoriatic arthritis in anti-TNF-na\u00efve patients from two Phase 3 ustekinumab trials","volume":"46","author":"McInnes","year":"2019","journal-title":"J Rheumatol"},{"key":"2020082623472017700_keaa062-B17","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/acr.23249","article-title":"Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis: results from the corrona psoriatic arthritis\/spondyloarthritis registry","volume":"69","author":"Mease","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2020082623472017700_keaa062-B18","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/acr.23174","article-title":"Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: incidence, prevalence, characteristics, and outcome","volume":"69","author":"Polachek","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2020082623472017700_keaa062-B19","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3899\/jrheum.121145","article-title":"Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis","volume":"40","author":"Carneiro","year":"2013","journal-title":"J Rheumatol"},{"key":"2020082623472017700_keaa062-B20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/rheumatology\/33.9.834","article-title":"Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease","volume":"33","author":"Jones","year":"1994","journal-title":"Rheumatology"},{"key":"2020082623472017700_keaa062-B21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ard.35.4.354","article-title":"Eye inflammation in psoriatic arthritis","volume":"35","author":"Lambert","year":"1976","journal-title":"Ann Rheum Dis"},{"key":"2020082623472017700_keaa062-B22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6061\/clinics\/2012(03)08","article-title":"Prevalence of eye disease in Brazilian patients with psoriatic arthritis","volume":"67","author":"Lima","year":"2012","journal-title":"Clinics"},{"key":"2020082623472017700_keaa062-B23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10067-014-2652-9","article-title":"Extra-articular manifestations in psoriatic arthritis patients","volume":"34","author":"Peluso","year":"2015","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/9\/2199\/33686239\/keaa062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/9\/2199\/33686239\/keaa062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T16:53:09Z","timestamp":1695660789000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/9\/2199\/5803188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,3,11]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa062","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,3,11]]}}}